atenolol and melanotan-ii

atenolol has been researched along with melanotan-ii in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Faier, A; Gabinet, Y; Gilon, C; Halbfinger, E; Haskell-Luevano, C; Hess, S; Hoffman, A; Lapidot, T; Linde, Y; Ovadia, O; Portillo, FP; Safrai, E; Shalev, DE; Swed, A; Winkler, I; Xiang, Z; Yarden, D	1

Other Studies

1 other study(ies) available for atenolol and melanotan-ii

Article	Year
Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity. Journal of medicinal chemistry, 2008, Feb-28, Volume: 51, Issue:4 Topics: Administration, Oral; Animals; Anti-Obesity Agents; Biological Availability; Brain; Cell Line; Humans; Injections, Intravenous; Intestinal Absorption; Ligands; Magnetic Resonance Spectroscopy; Male; Mice; Molecular Mimicry; Peptides, Cyclic; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Structure-Activity Relationship; Tissue Distribution	2008

Article

Year

Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity.

Journal of medicinal chemistry, 2008, Feb-28, Volume: 51, Issue:4

Topics: Administration, Oral; Animals; Anti-Obesity Agents; Biological Availability; Brain; Cell Line; Humans; Injections, Intravenous; Intestinal Absorption; Ligands; Magnetic Resonance Spectroscopy; Male; Mice; Molecular Mimicry; Peptides, Cyclic; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Structure-Activity Relationship; Tissue Distribution

2008